Have your own idea? Try our Stock Screener
Over the last 7 days, the Healthtech industry has risen 4.7%, driven by gains from Pro Medicus of 4.6%. Meanwhile, MedAdvisor actually underperformed within the industry, shrinking 31% in the last week. This means that the industry has gained 132% over the past year. As for the next few years, earnings are expected to grow by 21% per annum.
Has the Australian Healthtech Industry valuation changed over the past few years?
Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
---|---|---|---|---|---|---|
Thu, 31 Oct 2024 | AU$21.9b | AU$582.5m | -AU$63,139,686.81 | 243.6x | -347.5x | 37.7x |
Sat, 28 Sep 2024 | AU$19.6b | AU$578.2m | -AU$62,138,303.06 | 219.7x | -314.9x | 33.8x |
Mon, 26 Aug 2024 | AU$17.2b | AU$552.5m | -AU$67,778,692.81 | 107.1x | -254.4x | 31.2x |
Wed, 24 Jul 2024 | AU$15.5b | AU$535.1m | -AU$82,230,096.74 | 112.8x | -188.6x | 29x |
Fri, 21 Jun 2024 | AU$15.6b | AU$532.7m | -AU$81,517,015.86 | 113.7x | -191.5x | 29.3x |
Sun, 19 May 2024 | AU$13.9b | AU$567.2m | -AU$89,727,134.03 | 100.9x | -154.9x | 24.5x |
Tue, 16 Apr 2024 | AU$12.8b | AU$571.2m | -AU$103,464,554.64 | 93.1x | -123.4x | 22.4x |
Thu, 14 Mar 2024 | AU$12.2b | AU$571.0m | -AU$102,990,816.93 | 87x | -118.4x | 21.3x |
Sat, 10 Feb 2024 | AU$12.8b | AU$527.6m | -AU$134,517,049.97 | 110.1x | -95.2x | 24.3x |
Mon, 08 Jan 2024 | AU$11.3b | AU$527.3m | -AU$139,729,386.00 | 100.7x | -81.2x | 21.5x |
Wed, 06 Dec 2023 | AU$11.0b | AU$529.1m | -AU$107,089,199.00 | 98.6x | -103.2x | 20.9x |
Fri, 03 Nov 2023 | AU$9.9b | AU$525.9m | -AU$107,203,875.00 | 92.1x | -92.2x | 18.8x |
Sun, 01 Oct 2023 | AU$10.4b | AU$527.6m | -AU$112,059,669.00 | 95.4x | -92.6x | 19.7x |
Tue, 29 Aug 2023 | AU$9.3b | AU$524.0m | -AU$147,064,545.00 | 85.8x | -63.6x | 17.8x |
Thu, 27 Jul 2023 | AU$8.7b | AU$499.3m | -AU$152,969,272.00 | 91.2x | -57.1x | 17.5x |
Sat, 24 Jun 2023 | AU$8.5b | AU$499.4m | -AU$152,505,285.00 | 95.5x | -55.7x | 17x |
Mon, 22 May 2023 | AU$8.0b | AU$495.2m | -AU$145,783,044.00 | 88.6x | -54.7x | 16.1x |
Wed, 19 Apr 2023 | AU$8.1b | AU$493.0m | -AU$145,026,765.00 | 87.4x | -55.8x | 16.4x |
Fri, 17 Mar 2023 | AU$8.0b | AU$492.7m | -AU$143,930,689.00 | 86.5x | -55.4x | 16.2x |
Sun, 12 Feb 2023 | AU$8.5b | AU$440.0m | -AU$154,274,789.00 | 94.1x | -55.1x | 19.3x |
Tue, 10 Jan 2023 | AU$7.5b | AU$440.8m | -AU$154,777,614.00 | 81.9x | -48.6x | 17.1x |
Thu, 08 Dec 2022 | AU$7.6b | AU$445.5m | -AU$156,483,107.00 | 81.7x | -48.8x | 17.1x |
Sat, 05 Nov 2022 | AU$7.3b | AU$443.6m | -AU$157,129,789.00 | 76.3x | -46.2x | 16.4x |
Mon, 03 Oct 2022 | AU$6.8b | AU$439.2m | -AU$156,574,115.00 | 75x | -43.3x | 15.4x |
Wed, 31 Aug 2022 | AU$7.2b | AU$416.4m | -AU$140,069,804.00 | 73.1x | -51.3x | 17.3x |
Fri, 29 Jul 2022 | AU$6.7b | AU$384.5m | -AU$130,306,197.00 | 78.3x | -51.4x | 17.4x |
Sun, 26 Jun 2022 | AU$5.8b | AU$386.2m | -AU$131,700,982.00 | 69.7x | -44.2x | 15.1x |
Tue, 24 May 2022 | AU$6.1b | AU$382.3m | -AU$132,452,735.00 | 67.9x | -45.8x | 15.9x |
Thu, 21 Apr 2022 | AU$7.4b | AU$379.3m | -AU$133,814,284.00 | 85.3x | -55.5x | 19.6x |
Sat, 19 Mar 2022 | AU$6.8b | AU$380.3m | -AU$134,585,205.00 | 76.1x | -50.3x | 17.8x |
Mon, 14 Feb 2022 | AU$7.0b | AU$300.9m | -AU$137,842,587.00 | 99.5x | -51x | 23.4x |
Wed, 12 Jan 2022 | AU$7.8b | AU$301.0m | -AU$137,852,929.00 | 113.6x | -56.5x | 25.9x |
Fri, 10 Dec 2021 | AU$8.6b | AU$300.4m | -AU$137,057,881.00 | 126.5x | -62.6x | 28.6x |
Sun, 07 Nov 2021 | AU$9.0b | AU$295.9m | -AU$133,082,988.00 | 130.4x | -67.6x | 30.4x |
-67.6x
Which industries have driven the changes within the Australian Healthcare industry?
AU Market | -0.48% | |
Healthcare | -0.66% | |
Healthtech | 4.72% | |
Healthtech | 4.72% |
Which companies have driven the market over the last 7 days?
Company | Last Price | 7D | 1Y | Valuation | |
---|---|---|---|---|---|
PME Pro Medicus | AU$194.83 | 4.6% +AU$901.8m | 143.9% | PE245.9x | |
4DX 4DMedical | AU$0.53 | 3.9% +AU$8.2m | 14.0% | PS58x | |
PCK PainChek | AU$0.031 | 14.8% +AU$6.5m | -26.2% | PS19x | |
AYA Artrya | AU$0.53 | 11.6% +AU$4.3m | 140.9% | PB2.5x | |
CGS Cogstate | AU$0.98 | 2.1% +AU$3.5m | -34.9% | PE20.4x |